| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.8 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |